Navigation Links
Researchers gain insight into 100-year-old Haber-Bbosch process
Date:11/11/2011

For the past 100 years, the Haber-Bosch process has been used to convert atmospheric nitrogen into ammonia, which is essential in the manufacture of fertilizer. Despite the longstanding reliability of the process, scientists have had little understanding of how it actually works. But now a team of chemists, led by Patrick Holland of the University of Rochester, has new insight into how the ammonia is formed. Their findings are published in the latest issue of Science.

Holland calls nitrogen molecules "challenging." While they're abundant in the air around us, which makes them desirable for research and manufacturing, their strong triple bonds are difficult to break, making them highly unreactive. For the last century, the Haber-Bosch process has made use of an iron catalyst at extremely high pressures and high temperatures to break those bonds and produce ammonia, one drop at a time. The question of how this works, though, has not been answered to this day.

"The Haber-Bosch process is efficient, but it is hard to understand because the reaction occurs only on a solid catalyst, which is difficult to study directly," said Holland. "That's why we attempted to break the nitrogen using soluble forms of iron."

Holland and his team, which included Meghan Rodriguez and William Brennessel at the University of Rochester and Eckhard Bill of the Max Planck Institute for Bioinorganic Chemistry in Germany, succeeded in mimicking the process in solution. They discovered that an iron complex combined with potassium was capable of breaking the strong bonds between the nitrogen (N) atoms and forming a complex with an Fe3N2 core, which indicates that three iron (Fe) atoms work together in order to break the N-N bonds. The new complex then reacts with hydrogen (H2) and acid to form ammonia (NH3) -- something that had never been done by iron in solution before.

Despite the breakthrough, the Haber-Bosch process is not likely to be replaced
'/>"/>

Contact: Peter Iglinski
peter.iglinski@rochester.edu
585-273-4726
University of Rochester
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Robins & Morton completed a 67,000 SF ... for the New T-Mobile Financial Care Call Center. The ... demolition of the interior systems, replacement of all windows, ... spaces to accommodate employees. , KP Development’s Director ... to develop such a unique building for their customer, ...
(Date:4/1/2015)... 2015 In April, the Science Museum ... raise autism awareness by illuminating Richmond’s historic train station ... one of thousands of businesses, schools and organizations who ... lighting to brighten up the night sky – and ... collaborative effort is the 8th annual awareness campaign spearheaded ...
(Date:4/1/2015)... Royal River Natural Foods, a locally-owned independent natural ... found the amino acid creatine, which athletes typically use to ... pressure. , The report is part of the ... ,” which Royal River Natural Foods publishes each month as ... the latest in nutrition science. Also in the April issue, ...
(Date:4/1/2015)... NTOCC today launches the Knowledge & Resource Center, a ... improve care transitions and positively impact health outcomes. , ... to tools or resources that align with its mission ... through the promotion of public policy, and education and ... the Knowledge & Resource Center serves as a mechanism ...
(Date:4/1/2015)... CA, March 24, 2015 (PRWEB) April 01, 2015 ... by many, the most extreme jungle adventure you could ever ... many as 23 days. Endorsed by the Philippine Department of ... people have visited the rainforest, but very few people have ... Bergman, Chief Adventure Officer. , Armed with nothing more than ...
Breaking Medicine News(10 mins):Health News:Robins & Morton Transforms Former Southern Living Media Services Building for New T-Mobile Financial Care Call Center 2Health News:New Study Finds Strength-Building Supplement Improves Circulation, Retailer Reports 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3
... of Radiotherapy and Oncology at the Post Graduate Institute ... //Tuesday as National Cancer Awareness Day, organizing a poster ... ,The PGI Director, Dr. K.K. Talwar, stated that this ... the early detection and prevention of cancer. He said, ...
... Hong Kong have been advised to build a three-month stockpile ... of a bird flu pandemic, a news report said Tuesday. ... 60,000 registered US citizens in the former British colony urging ... flu season. ,It suggests stockpiling 4.5 litres of ...
... Diabetics will soon have transformed lives through an artificial ... continuously //as well as provides insulin automatically. This could ... tests and injections. ,Around 350,000 Britons ... raises its head in childhood or young adulthood. ...
... dilemma; whether to preserve the Roman Catholic Church's "traditional ... //policy that gives us an effective weapon against AIDS ... and infallibility to new challenges," according to Peter Boulay, ... ,Cardinal Javier Lozano Barragan in April said ...
... Kong health director Margaret Chan Tuesday emerged as favourite ... Organisation (WHO). // ,The 60-year-old obstetrician, who led ... five-person shortlist of candidates released overnight ahead of a ... got 32 votes in the first round of voting ...
... with smoking have resulted in delayed healing in mice. ... million illnesses //in U.S., having harmful effects on variety ... Smoking. Studies have proved that the toxins contained in ... In addition, smokers are highly prone to hip ...
Cached Medicine News:Health News:Cure of Cancer Requires Early detection 2Health News:Lives of Diabetics Transformed 2Health News:Consequences Of Smoking On Fractures & Ligament Injuries 2
(Date:4/1/2015)... 1, 2015  Hologic, Inc. (NASDAQ: HOLX ) ... 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. ... Company, the trustee, paying agent and conversion agent for ... notes.  This conversion right is subject to the terms ... of December 10, 2007, as supplemented by the second ...
(Date:4/1/2015)... 2015  The first national study to look ... treat attention-deficit/hyperactivity disorder (ADHD) among children ages 4-17 ... with ADHD were receiving behavioral therapy in 2009-2010 ... Prevention (CDC) study, "Treatment of Attention-Deficit/Hyperactivity Disorder among ... in The Journal of Pediatrics provides ...
(Date:4/1/2015)... , April 1, 2015  The fairness of the ... "Company") by Teva Pharmaceutical Industries ("Teva") is being investigated ... law firm.  The investigation focuses on possible breaches of ... Board of Directors of ASPX for agreeing to sell ... Company announced a definitive agreement for Teva to acquire ...
Breaking Medicine Technology:Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2
... Israel--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPharma (TASE:CFBI), a ... Exchange, proceeds with the development of its,third drug ... is currently,in clinical trials and CF102, which is ... the EUALR annual congress of,rheumatology in-vitro and in ...
... of SLE,disease at 52 Weeks and demonstrated ... ROCKVILLE, Md., June 14, 2007 /PRNewswire-FirstCall/ -- ... of Phase 2,trial data demonstrating that LymphoStat-B(R) ... was well tolerated and improved quality of ...
Cached Medicine Technology:Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 8